Nifty is Bullish but not Fully. Waiting for Confirmation move

115
So just like we anticipated, Nifty opened with a gap down — and gave a beautiful bounce right from the start. CNXPHARMA led the charge exactly as we discussed yesterday, proving once again how preparation beats prediction.

Nifty's Pivot has now shifted to 24755, and the Pivot Percentile has climbed to 0.26 — clear sign that we may see another directional move tomorrow. The market is heating up again.

Today's candle on NIFTY is a classic liquidity grab — trapped shorts at the bottom and a clean reversal. That has flipped the intraday trend to the upside. From here, any dip should be seen as a buying opportunity — but only with a strict stoploss.

Support for Nifty stands strong at 24800, while the key resistance remains at 25000. If momentum holds, we might just test that level tomorrow.

Now coming to BANKNIFTY — the pivot is at 56120 with support around 56000. This index also looks bullish on the intraday timeframe, showing signs of strength building up.

Remember clearly that the market is just bouncy on intraday and a clear bullish sign is still not visible. So trade with that in mind. Use tight Stoploss.

On the sectoral front, #Fertilizer and NIFTY_MS_IT_TELCM stocks are catching our attention. Both showing solid accumulation patterns and might lead the next leg of momentum.

As for trades, today was another green day. Here's how the setups I traded recently played out:

1. HIRECT – locked 19.99%
2. PARADEEP – up 8.57%
3. TATACHEM – added 7.03%
4. #DHANUKA – 6.01% in the green
5. #JBCHEPHARMA – gave a clean 5%
6. #IXIGO – hit 5% upside
7. #PRIVISCL – moved more than 5%

Another day of solid execution following my Earnings Pivot Strategy.

That’s it for today. Rest well, manage your risk, and let’s get ready for tomorrow.
Stay sharp and trade safe.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.